Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010562
Filing Date
2021-08-05
Accepted
2021-08-05 16:18:57
Documents
82
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q coll-20210630x10q.htm   iXBRL 10-Q 1799784
2 EX-10.1 coll-20210630xex10d1.htm EX-10.1 103185
3 EX-31.1 coll-20210630xex31d1.htm EX-31.1 13407
4 EX-31.2 coll-20210630xex31d2.htm EX-31.2 13431
5 EX-32.1 coll-20210630xex32d1.htm EX-32.1 7687
6 EX-32.2 coll-20210630xex32d2.htm EX-32.2 7525
7 GRAPHIC coll-20210630x10q001.jpg GRAPHIC 10048
  Complete submission text file 0001558370-21-010562.txt   8702335

Data Files

Seq Description Document Type Size
8 EX-101.SCH coll-20210630.xsd EX-101.SCH 60477
9 EX-101.CAL coll-20210630_cal.xml EX-101.CAL 68534
10 EX-101.DEF coll-20210630_def.xml EX-101.DEF 229179
11 EX-101.LAB coll-20210630_lab.xml EX-101.LAB 527492
12 EX-101.PRE coll-20210630_pre.xml EX-101.PRE 412969
13 EXTRACTED XBRL INSTANCE DOCUMENT coll-20210630x10q_htm.xml XML 1742487
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37372 | Film No.: 211148479
SIC: 2834 Pharmaceutical Preparations